<DOC>
	<DOCNO>NCT00489528</DOCNO>
	<brief_summary>The purpose study compare physical function lean body mass patient get different dos somatropin compare patient get drug .</brief_summary>
	<brief_title>Growth Hormone Treatment HIV-Associated Wasting</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Wasting Syndrome</mesh_term>
	<mesh_term>HIV Wasting Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Have clearly document HIV infection , determine presence HIV confirm one following : Western blot , immunofluorescence assay , HIV culture , polymerase chain reaction ( PCR ) amplification , branch DNA ( bDNA ) signal amplification presence p24 antigen . These test may perform time past , result must available review Serono prior entry study . 2 . Have evidence AIDS wasting , least one following : Documented unintentional weight loss least 10 % , In absence unintentional weight loss 10 % , weight le 90 % ideal body weight ( Metropolitan Height Weight Tables ) , In absence unintentional weight loss 10 % , body mass index &lt; 20 kg/m² . 3 . Be least 18 year age . 4 . Be receive least 90 % estimate caloric requirement current nutritional regimen , accord formal nutritional analysis . 5 . Meet follow laboratory test criterion week 4 visit ( pre study screen ) : AST , ALT , amylase &lt; 3 time upper limit normal . Fasting triglyceride level &lt; 500 mg/dl ( &lt; 5.64 mmol/l ) . Fasting glucose &lt; 110 mg/dl ( &lt; 6.1mmol/l ) . 6 . Be take antiretroviral medication approve available Treatment IND ( US ) temporary approval ( outside US ) . The subject must antiretroviral therapy least 8 week prior study Day 1 . The subject must agree change antiviral regimen 12 week study drug administration ( unless medically mandate ) . 7 . Be capable completing require study activity assessment ( include require exercise performance test ) . 8 . Understand sign inform consent document . 1 . Any medical history following : Pancreatitis . Carpal tunnel syndrome ( unless resolve surgical release ) . Glucose intolerance [ purpose protocol define fast blood glucose ≥ 110 mg/dl ( 6.1 mmol/l ) , 2 hour/random blood glucose ≥ 140 mg/dl ( 7.8 mg/dl ) ] . Angina pectoris . Coronary artery disease . Any disorder associate moderate severe edema ( e.g. , cirrhosis , nephrosis , congestive heart failure , lymphedema ) . Allergy hypersensitivity growth hormone . 2 . Any following medical condition : Active AIDSdefining opportunistic infection . Any active malignancy , except localize cutaneous Kaposi 's sarcoma ( few 10 lesion , none exceed 2 cm size , active therapy ) . A central nervous system ( CNS ) mass , CNS process associate active neurological finding . Chronic diarrhea ( defined 6 liquid stool per day ) . Unstable untreated hypertension . 3 . Patients acute critical illness intensive care unit due complication follow open heart abdominal surgery , multiple accidental trauma , acute respiratory failure . 4 . Either follow aspect medical regimen 30 day prior study entry ( 60 day prior receive study drug ) : New systemic therapy opportunistic infection . New therapy wasting , include parenteral oral hyperalimentation , tube feeding , anabolic progestational agent , appetite stimulant . 5 . Prior radiation therapy systemic chemotherapy . 6 . Use glucocorticoid within past six month growth hormone within past year . 7 . An untreated suspect serious systemic infection , persistent fever &gt; 101°F ( 38.5°C ) 30 day prior study entry . 8 . Evidence gastrointestinal ( GI ) bleeding , obstruction , malabsorption determine Investigator . 9 . Active substance abuse would prevent informed consent compliance study activity . 10 . Dementia would preclude patient give informed consent comply requirement protocol . 11 . If female , neither pregnant breast feeding . 12 . Use investigational agent another protocol unless discuss approve advance Serono 's Therapeutic Director .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>serostim</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Body Composition</keyword>
</DOC>